I-MOVE-COVID-19 – Multidisciplinary European network for research, prevention and control of the COVID-19 Pandemic
The I-MOVE-COVID-19 consortium, coordinated by Epiconcept, was created following the European Commission’s Call for Proposals H2020 «Advancing Knowledge for the Clinical and Public Health Response to the Emerging Coronavirus Epidemic». It brings together many partners already involved in the I-MOVE (Influenza – Monitoring Vaccine Effectiveness in Europe) network.
The I-MOVE-COVID-19 consortium aims to obtain epidemiological and clinical information on patients with COVID-19 as well as virological information on SARS-CoV-2, through (a) provision of a flexible surveillance platform (adaptable to the epidemiological situation), (b) research studies and (c) evaluation of public health interventions (e.g. vaccination, antivirals), in order to contribute to the knowledge base, guide patient management, and inform the public health response. This will be achieved through adaptation and expansion of the existing, long-running, Europe-wide influenza surveillance network (I-MOVE) to include COVID-19. The network includes primary care networks, hospitals, and national laboratory reference centers in 10 countries across the WHO European Region.
- Funder: European Commission
- Project ID: 101003673
- Principal Investigator: Amelia Fernandez Sierra
- Center: University Hospital San Cecilio
- Rol in the project: Third part (ISCIII)
- Duration: 2020 – 2022